Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: An analysis from a regional healthcare network

Pierre Bories; Sarah Bertoli; Emilie Bérard; Julie Laurent; Eliane Duchayne; Audrey Sarry; Eric Delabesse; Odile Beyne-Rauzy; Françoise Huguet; Christian Récher

doi:10.1002/ajh.23848

Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: An analysis from a regional healthcare network

American Journal of Hematology ◽

10.1002/ajh.23848 ◽

2014 ◽

Vol 89 (12) ◽

pp. E244-E252 ◽

Cited By ~ 26

Author(s):

Pierre Bories ◽

Sarah Bertoli ◽

Emilie Bérard ◽

Julie Laurent ◽

Eliane Duchayne ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Supportive Care ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Healthcare Network ◽

Acute Myeloid

Download Full-text

Impact of intensive chemotherapy versus supportive care on quality of life (QOL) of older adults with newly diagnosed acute myeloid leukemia (AML)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8187 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8187-8187

Author(s):

M. Leach ◽

S. M. H. Alibhai ◽

M. D. Minden ◽

V. Gupta ◽

A. Schattner ◽

...

Keyword(s):

Quality Of Life ◽

Older Adults ◽

Acute Myeloid Leukemia ◽

Supportive Care ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726102457.793548555 ◽

2018 ◽

Author(s):

Stephen Nimer

Keyword(s):

Acute Myeloid Leukemia ◽

Supportive Care ◽

Older Patients ◽

Myeloid Leukemia ◽

Best Supportive Care ◽

Gemtuzumab Ozogamicin ◽

Phase Iii ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2022140 ◽

2022 ◽

pp. 1-9

Author(s):

Noémie Gadaud ◽

Harmony Leroy ◽

Emilie Bérard ◽

Suzanne Tavitian ◽

Thibaut Leguay ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Supportive Care ◽

Myeloid Leukemia ◽

Best Supportive Care ◽

Intensive Chemotherapy ◽

Registry Study ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

Case Medical Research ◽

10.31525/ct1-nct03839771 ◽

2000 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Maintenance Therapy ◽

Induction Therapy ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Consolidation Therapy ◽

Newly Diagnosed ◽

Idh2 Mutation ◽

Acute Myeloid

Download Full-text

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

Case Medical Research ◽

10.31525/ct1-nct03978858 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10197.467594 ◽

2006 ◽

Author(s):

Mayumi Mori

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Acute Myeloid

Download Full-text

Venetoclax combinations induce high response rates in newly diagnosed Acute Myeloid Leukemia patients ineligible for intensive chemotherapy in routine practice

American Journal of Hematology ◽

10.1002/ajh.26190 ◽

2021 ◽

Author(s):

Arie Apel ◽

Yakir Moshe ◽

Yishai Ofran ◽

Alexander Gural ◽

Ofir Wolach ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Response Rates ◽

High Response ◽

Routine Practice ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia

Annals of Hematology ◽

10.1007/s002770050273 ◽

1997 ◽

Vol 74 (3) ◽

pp. 143-147 ◽

Cited By ~ 13

Author(s):

M. J. M. Pouwels ◽

J. P. Donnelly ◽

J. M. M. Raemaekers ◽

P. E. Verweij ◽

B. E. de Pauw

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Clostridium Septicum ◽

Neutropenic Enterocolitis ◽

Acute Myeloid

Download Full-text

Hypomethylating Agents Versus Intensive Chemotherapy in Older Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2018.07.051 ◽

2018 ◽

Vol 18 ◽

pp. S201-S202

Author(s):

Chetasi Talati ◽

Andrew Kuykendall ◽

Najla Al Ali ◽

Jongphil Kim ◽

Marina Sehovic ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Blood Cell ◽

Cell Count ◽

White Blood Cell Count ◽

Older Patients ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Hypomethylating Agents ◽

Blood Cell Count ◽

Acute Myeloid

Download Full-text

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Leukemia Research ◽

10.1016/j.leukres.2018.10.011 ◽

2018 ◽

Vol 75 ◽

pp. 29-35 ◽

Cited By ~ 4

Author(s):

Pankit Vachhani ◽

Raed Al Yacoub ◽

Austin Miller ◽

Fan Zhang ◽

Tara L. Cronin ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Single Center ◽

Single Center Experience ◽

Acute Myeloid

Download Full-text